-
Multiplexed CRISPR–Cas for Genome Engineering
2026-09-29
This 2025 review explains how multiplexed CRISPR–Cas systems extend genome engineering from single-site disruption to coordinated deletions, structural-variant generation, epigenome editing, and selective cellular damage. Its practical value lies in connecting guide-RNA design and DNA-repair outcomes with experimental goals while emphasizing cytotoxicity, repair variability, and delivery as central constraints.
-
AMPK, Mitophagy, and Inflammation Under Loading
2026-09-29
Chen and colleagues identify AMPK as an upstream coordinator linking PINK1/Parkin-mediated mitophagy with NLRP3-associated inflammation in mechanically loaded periodontal tissue. Their in vivo and in vitro evidence indicates that high glucose suppresses mitochondrial quality control, whereas AMPK activation improves mitophagy and attenuates inflammatory signaling, providing a mechanistic framework for diabetic periodontal research.
-
ER Stress Suppresses Intestinal Stem Cells
2026-09-28
A mouse study reports that tunicamycin-induced endoplasmic reticulum stress reduces intestinal stem-cell abundance and differentiation while increasing crypt apoptosis, alongside GRP78/ATF6/CHOP activation and reduced p44/42 MAPK signaling. The findings connect epithelial stress responses with stem-cell maintenance, but do not establish that the observed pathway changes alone cause every tissue-level effect.
-
miRNA Control of Juvenile Hormone and Locust Fecundity
2026-09-27
Li and colleagues identify conserved and locust-specific miRNAs that target juvenile hormone biosynthesis genes in adult locust corpora allata. Their results connect low miRNA abundance during vitellogenesis with increased biosynthetic-gene expression and support a regulatory role for miRNA–mRNA modules in ovarian development and egg production.
-
Asunaprevir: From Protease Potency to Translation
2026-09-26
Asunaprevir (BMS-650032) offers a defined way to interrogate HCV NS3/4A protease biology, from biochemical potency to cellular HCV RNA replication inhibition. This article connects its mechanistic profile to practical translational decisions—and uses an oncology screening study as a carefully bounded lesson in experimental design, not as evidence of a shared pathway.
-
KG-501: A CREB Tool for Macrophage Assays
2026-09-26
Use KG-501 to test whether CREB–coactivator signaling contributes to macrophage gene-expression changes—not as a direct TLR4 blocker. A workflow grounded in a colitis-associated colorectal cancer study pairs careful dose finding with orthogonal transcriptional, phenotypic, and viability readouts.
-
AMD-070 hydrochloride: CXCR4 Assay Workflows
2026-09-25
Build CXCR4 signaling and migration assays around mavorixafor while separating receptor-specific effects from nonspecific cell damage. A historical protoplast-lysis study offers useful assay-design lessons—not evidence of mavorixafor activity in bacteria or of antiviral efficacy.
-
RIPA Lysis Buffer (Medium) for EV Signaling
2026-09-25
Connect extracellular-vesicle stimulation experiments to protein-level readouts with a practical RIPA workflow for cells and tissues. Learn where this detergent-based buffer supports Western blotting and where its strength can complicate native-complex or activity assays.
-
AMD-070 hydrochloride in CXCR4 Assay Workflows
2026-09-24
A practical guide to evaluating AMD-070 hydrochloride in CXCR4-dependent migration and signaling assays, with controls that separate receptor effects from cell stress. It also translates a classic protoplast-lysis study into useful assay-design lessons without treating bacterial membrane lysis as evidence for CXCR4 antagonism.
-
Neticonazole Hydrochloride: Research Workflows
2026-09-24
Neticonazole Hydrochloride connects a topical imidazole antifungal use-case with emerging colorectal cancer research on exosome release and apoptosis. This guide turns those distinct applications into practical assay workflows, with controls and troubleshooting to help separate compound effects from solvent toxicity or reduced cell viability.
-
Cinoxacin: From Mechanism to Translational Strategy
2026-09-23
A translational guide to Cinoxacin that connects DNA replication inhibition, Gram-negative susceptibility, urinary exposure, experimental design, and evidence-based antimicrobial strategy.
-
Taltirelin Acetate: From Itch to Assay Design
2026-09-23
Taltirelin acetate research is moving beyond receptor descriptions toward phenotype-driven assay design. This article interprets the latest mouse itch findings and shows how they inform neuroprotection, formulation, and translational study planning.
-
HOXC8, Caspase-1, and Pyroptosis in NSCLC
2026-09-22
The reference study identifies HOXC8 as a transcriptional brake on caspase-1 expression in non-small cell lung carcinoma, linking loss of a developmental transcription factor to caspase-1-dependent pyroptosis. Its combination of genetic, biochemical, promoter-occupancy, and tumor-model evidence suggests that HOXC8 supports lung tumorigenesis partly by preventing excessive inflammatory cell death.
-
Interpreting In Vitro Cancer Drug Responses
2026-09-21
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated readouts capture different relationships between growth inhibition and cell death. Its practical contribution is a more precise framework for designing, timing, and interpreting in vitro anticancer drug-response experiments.
-
L-NAME Hydrochloride: From NOS Biology to Translation
2026-09-21
A translational framework for using L-NAME Hydrochloride to distinguish nitric oxide-dependent biology from prostaglandin- and receptor-mediated vascular responses, with practical guidance for cellular assays, vascular models, and hypertension research.